Saturday, July 11, 2026

pharma · Calculus, Dental · Oral Malodor

Colgate Oral Pharmaceuticals

Colgate Oral Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

AU HQ
TGA registrant Type
Company details
Status
Public
HQ
AU
Programs
2
Drugs
0
Patents
0
Intelligence · Drug Pipeline

Colgate Oral Pharmaceuticals pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Colgate Oral Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →